

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of synapse maturation (GO:0090129) | 4.81658448 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.65470061 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 4.65470061 |
| 4 | cerebellar granule cell differentiation (GO:0021707) | 4.55888407 |
| 5 | synaptic vesicle maturation (GO:0016188) | 4.40453835 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.35815978 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 4.35815978 |
| 8 | amino acid import (GO:0043090) | 4.32807601 |
| 9 | locomotory exploration behavior (GO:0035641) | 4.29551273 |
| 10 | potassium ion homeostasis (GO:0055075) | 4.26450947 |
| 11 | cell communication by electrical coupling (GO:0010644) | 4.26192264 |
| 12 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.11573811 |
| 13 | aromatic amino acid family catabolic process (GO:0009074) | 4.08555626 |
| 14 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.08410704 |
| 15 | axon ensheathment in central nervous system (GO:0032291) | 4.06874835 |
| 16 | central nervous system myelination (GO:0022010) | 4.06874835 |
| 17 | alpha-linolenic acid metabolic process (GO:0036109) | 4.06434559 |
| 18 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 4.00301230 |
| 19 | potassium ion import (GO:0010107) | 3.96536921 |
| 20 | neuromuscular process controlling balance (GO:0050885) | 3.95925254 |
| 21 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.92924165 |
| 22 | cellular sodium ion homeostasis (GO:0006883) | 3.89859455 |
| 23 | glutamate metabolic process (GO:0006536) | 3.89344545 |
| 24 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.86432038 |
| 25 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.82168943 |
| 26 | glutamate secretion (GO:0014047) | 3.79829205 |
| 27 | gamma-aminobutyric acid transport (GO:0015812) | 3.79271669 |
| 28 | vocalization behavior (GO:0071625) | 3.78764860 |
| 29 | bile acid biosynthetic process (GO:0006699) | 3.77890491 |
| 30 | positive regulation of dendritic spine development (GO:0060999) | 3.76974263 |
| 31 | kynurenine metabolic process (GO:0070189) | 3.72470938 |
| 32 | regulation of ARF protein signal transduction (GO:0032012) | 3.72046992 |
| 33 | neuronal ion channel clustering (GO:0045161) | 3.70617542 |
| 34 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.70184355 |
| 35 | regulation of synaptic plasticity (GO:0048167) | 3.70160584 |
| 36 | postsynaptic membrane organization (GO:0001941) | 3.66025073 |
| 37 | regulation of synapse maturation (GO:0090128) | 3.63120217 |
| 38 | indolalkylamine catabolic process (GO:0046218) | 3.59635389 |
| 39 | tryptophan catabolic process (GO:0006569) | 3.59635389 |
| 40 | indole-containing compound catabolic process (GO:0042436) | 3.59635389 |
| 41 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.55924798 |
| 42 | synaptic vesicle endocytosis (GO:0048488) | 3.55361717 |
| 43 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.52956032 |
| 44 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.47905393 |
| 45 | synaptic vesicle exocytosis (GO:0016079) | 3.45138476 |
| 46 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.44470003 |
| 47 | high-density lipoprotein particle remodeling (GO:0034375) | 3.43661650 |
| 48 | neurotransmitter secretion (GO:0007269) | 3.43143699 |
| 49 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.42866061 |
| 50 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.41646997 |
| 51 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.41075963 |
| 52 | regulation of neurotransmitter secretion (GO:0046928) | 3.40277551 |
| 53 | cell communication involved in cardiac conduction (GO:0086065) | 3.37438577 |
| 54 | cerebellar Purkinje cell layer development (GO:0021680) | 3.32575126 |
| 55 | urea metabolic process (GO:0019627) | 3.32300339 |
| 56 | urea cycle (GO:0000050) | 3.32300339 |
| 57 | cellular ketone body metabolic process (GO:0046950) | 3.30707280 |
| 58 | glyoxylate metabolic process (GO:0046487) | 3.29921535 |
| 59 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.29067138 |
| 60 | tryptophan metabolic process (GO:0006568) | 3.29029552 |
| 61 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.24705038 |
| 62 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.24117925 |
| 63 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.23523599 |
| 64 | cysteine metabolic process (GO:0006534) | 3.23080978 |
| 65 | dicarboxylic acid catabolic process (GO:0043649) | 3.22283641 |
| 66 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.21025285 |
| 67 | bile acid metabolic process (GO:0008206) | 3.18885026 |
| 68 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.18762752 |
| 69 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.18684182 |
| 70 | activation of protein kinase A activity (GO:0034199) | 3.17330968 |
| 71 | regulation of vesicle fusion (GO:0031338) | 3.12783063 |
| 72 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.12563686 |
| 73 | sulfur amino acid catabolic process (GO:0000098) | 3.12386266 |
| 74 | negative regulation of fibrinolysis (GO:0051918) | 3.12148667 |
| 75 | dendritic spine organization (GO:0097061) | 3.11478226 |
| 76 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.10490596 |
| 77 | positive regulation of neurotransmitter transport (GO:0051590) | 3.08792699 |
| 78 | regulation of synapse structural plasticity (GO:0051823) | 3.08442209 |
| 79 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.07382926 |
| 80 | exploration behavior (GO:0035640) | 3.06512987 |
| 81 | lysine metabolic process (GO:0006553) | 3.05248741 |
| 82 | lysine catabolic process (GO:0006554) | 3.05248741 |
| 83 | complement activation, alternative pathway (GO:0006957) | 3.04810338 |
| 84 | nitrogen cycle metabolic process (GO:0071941) | 3.03706323 |
| 85 | reverse cholesterol transport (GO:0043691) | 3.03071943 |
| 86 | alpha-amino acid catabolic process (GO:1901606) | 3.02997456 |
| 87 | regulation of neurotransmitter transport (GO:0051588) | 3.02144053 |
| 88 | cellular modified amino acid catabolic process (GO:0042219) | 3.01710222 |
| 89 | regulation of fibrinolysis (GO:0051917) | 3.01164010 |
| 90 | layer formation in cerebral cortex (GO:0021819) | 2.99890191 |
| 91 | regulation of protein activation cascade (GO:2000257) | 2.98763145 |
| 92 | regulation of dendritic spine development (GO:0060998) | 2.98667371 |
| 93 | serine family amino acid catabolic process (GO:0009071) | 2.98643428 |
| 94 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.98064638 |
| 95 | acidic amino acid transport (GO:0015800) | 2.96551346 |
| 96 | regulation of postsynaptic membrane potential (GO:0060078) | 2.95335914 |
| 97 | positive regulation of dendrite development (GO:1900006) | 2.95049375 |
| 98 | protein carboxylation (GO:0018214) | 2.93640037 |
| 99 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.93640037 |
| 100 | dendritic spine morphogenesis (GO:0060997) | 2.92405391 |
| 101 | cellular amino acid catabolic process (GO:0009063) | 2.90646760 |
| 102 | protein-lipid complex remodeling (GO:0034368) | 2.89804576 |
| 103 | macromolecular complex remodeling (GO:0034367) | 2.89804576 |
| 104 | plasma lipoprotein particle remodeling (GO:0034369) | 2.89804576 |
| 105 | regulation of synaptic vesicle transport (GO:1902803) | 2.88723526 |
| 106 | protein localization to synapse (GO:0035418) | 2.87200958 |
| 107 | neuron-neuron synaptic transmission (GO:0007270) | 2.86501565 |
| 108 | short-chain fatty acid metabolic process (GO:0046459) | 2.85708079 |
| 109 | aromatic amino acid family metabolic process (GO:0009072) | 2.84841486 |
| 110 | regulation of cholesterol esterification (GO:0010872) | 2.84692767 |
| 111 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.84590106 |
| 112 | negative regulation of cholesterol transport (GO:0032375) | 2.84212991 |
| 113 | negative regulation of sterol transport (GO:0032372) | 2.84212991 |
| 114 | neuron cell-cell adhesion (GO:0007158) | 2.83682514 |
| 115 | ketone body metabolic process (GO:1902224) | 2.83252899 |
| 116 | cell migration in hindbrain (GO:0021535) | 2.83139693 |
| 117 | synaptic transmission, glutamatergic (GO:0035249) | 2.81531397 |
| 118 | mating behavior (GO:0007617) | 2.80857722 |
| 119 | dicarboxylic acid transport (GO:0006835) | 2.80748533 |
| 120 | coenzyme catabolic process (GO:0009109) | 2.80484102 |
| 121 | regulation of triglyceride catabolic process (GO:0010896) | 2.78947639 |
| 122 | cellular potassium ion homeostasis (GO:0030007) | 2.78676205 |
| 123 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.78344784 |
| 124 | regulation of synaptic transmission (GO:0050804) | 2.77060514 |
| 125 | regulation of complement activation (GO:0030449) | 2.76503292 |
| 126 | neuronal action potential propagation (GO:0019227) | 2.76022066 |
| 127 | neuromuscular process (GO:0050905) | 2.75132030 |
| 128 | aspartate family amino acid catabolic process (GO:0009068) | 2.74821043 |
| 129 | regulation of cholesterol homeostasis (GO:2000188) | 2.74023574 |
| 130 | regulation of bile acid biosynthetic process (GO:0070857) | 2.74004098 |
| 131 | acylglycerol homeostasis (GO:0055090) | 2.73596805 |
| 132 | triglyceride homeostasis (GO:0070328) | 2.73596805 |
| 133 | alanine transport (GO:0032328) | 2.73244162 |
| 134 | tyrosine metabolic process (GO:0006570) | 2.73107331 |
| 135 | L-amino acid import (GO:0043092) | 2.73041295 |
| 136 | sodium ion export (GO:0071436) | 2.72882328 |
| 137 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.72448330 |
| 138 | drug catabolic process (GO:0042737) | 2.72135098 |
| 139 | neurotransmitter transport (GO:0006836) | 2.71117765 |
| 140 | neurotransmitter uptake (GO:0001504) | 2.70829903 |
| 141 | regulation of neurotransmitter levels (GO:0001505) | 2.70816156 |
| 142 | long-term memory (GO:0007616) | 2.69954472 |
| 143 | amino-acid betaine metabolic process (GO:0006577) | 2.69339891 |
| 144 | chemosensory behavior (GO:0007635) | 2.68785137 |
| 145 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.67930865 |
| 146 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.67313351 |
| 147 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.66120665 |
| 148 | glutamate receptor signaling pathway (GO:0007215) | 2.65623985 |
| 149 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.64084585 |
| 150 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.63155039 |
| 151 | positive regulation of membrane potential (GO:0045838) | 2.63030293 |
| 152 | regulation of cell communication by electrical coupling (GO:0010649) | 2.62611143 |
| 153 | regulation of dendrite morphogenesis (GO:0048814) | 2.62502341 |
| 154 | L-glutamate transport (GO:0015813) | 2.62217496 |
| 155 | membrane depolarization (GO:0051899) | 2.61879330 |
| 156 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.61367046 |
| 157 | glycine transport (GO:0015816) | 2.60649417 |
| 158 | neuromuscular synaptic transmission (GO:0007274) | 2.60628097 |
| 159 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.59803219 |
| 160 | membrane depolarization during action potential (GO:0086010) | 2.58301881 |
| 161 | establishment of synaptic vesicle localization (GO:0097480) | 2.56227035 |
| 162 | synaptic vesicle transport (GO:0048489) | 2.56227035 |
| 163 | vesicle docking involved in exocytosis (GO:0006904) | 2.54820172 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.75218571 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.91714962 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.36814196 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.75573927 |
| 5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.64538300 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.43710783 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.40174985 |
| 8 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.37660189 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.36668465 |
| 10 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.33546025 |
| 11 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.21906410 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.21644305 |
| 13 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.19680736 |
| 14 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.17455157 |
| 15 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.17455157 |
| 16 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.13718267 |
| 17 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.11747431 |
| 18 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.11029797 |
| 19 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.07122254 |
| 20 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.05333253 |
| 21 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.96550284 |
| 22 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.96087036 |
| 23 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.96082797 |
| 24 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.88028385 |
| 25 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.87991230 |
| 26 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.86344079 |
| 27 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.82744431 |
| 28 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.81908355 |
| 29 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.78734191 |
| 30 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.77439054 |
| 31 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.74788559 |
| 32 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.73441676 |
| 33 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.72789366 |
| 34 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.71244452 |
| 35 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.70442460 |
| 36 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.69448685 |
| 37 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.68459823 |
| 38 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.67862962 |
| 39 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.65788058 |
| 40 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.61207067 |
| 41 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.58940905 |
| 42 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.52335291 |
| 43 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.49065739 |
| 44 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.48180157 |
| 45 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.45771796 |
| 46 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.38431464 |
| 47 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.36983330 |
| 48 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.35769506 |
| 49 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.35693814 |
| 50 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.35225758 |
| 51 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.34200545 |
| 52 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.33852144 |
| 53 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.33636725 |
| 54 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.33472014 |
| 55 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.32076691 |
| 56 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.31785278 |
| 57 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.30995320 |
| 58 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.29991090 |
| 59 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.29813788 |
| 60 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.29722794 |
| 61 | P68_20966046_ChIP-Seq_HELA_Human | 1.29197883 |
| 62 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.28846251 |
| 63 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.27892070 |
| 64 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.23245854 |
| 65 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.21464406 |
| 66 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.21045738 |
| 67 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.20565927 |
| 68 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.19719466 |
| 69 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.18982339 |
| 70 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.14492918 |
| 71 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.13772450 |
| 72 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.11480878 |
| 73 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.08398029 |
| 74 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.08287800 |
| 75 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.07772126 |
| 76 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.07752065 |
| 77 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.07057496 |
| 78 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.06709356 |
| 79 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.06537038 |
| 80 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.06192580 |
| 81 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.05721073 |
| 82 | KDM2B_26808549_Chip-Seq_K562_Human | 1.05702905 |
| 83 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.04023885 |
| 84 | AR_19668381_ChIP-Seq_PC3_Human | 1.03899843 |
| 85 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.03641948 |
| 86 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.03387584 |
| 87 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.03299314 |
| 88 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.02514559 |
| 89 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.01624762 |
| 90 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.01124579 |
| 91 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.00876463 |
| 92 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.00831977 |
| 93 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.00676882 |
| 94 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.99992890 |
| 95 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.99711046 |
| 96 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.98862562 |
| 97 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.98251454 |
| 98 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.97513945 |
| 99 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.97455988 |
| 100 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.96719295 |
| 101 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.95407565 |
| 102 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.95300705 |
| 103 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95033377 |
| 104 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.94756240 |
| 105 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.94283745 |
| 106 | * GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.93386815 |
| 107 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.92525515 |
| 108 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.92364207 |
| 109 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.92007520 |
| 110 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.91792716 |
| 111 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91097187 |
| 112 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91008828 |
| 113 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.90269907 |
| 114 | STAT3_23295773_ChIP-Seq_U87_Human | 0.89350781 |
| 115 | AR_25329375_ChIP-Seq_VCAP_Human | 0.88865830 |
| 116 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.88480324 |
| 117 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.88043577 |
| 118 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.86925720 |
| 119 | SA1_27219007_Chip-Seq_Bcells_Human | 0.85536327 |
| 120 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.84430885 |
| 121 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.84101550 |
| 122 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.83991045 |
| 123 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.83816243 |
| 124 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.83815148 |
| 125 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.83384651 |
| 126 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.83339502 |
| 127 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.82978024 |
| 128 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.82912539 |
| 129 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.82835142 |
| 130 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.82468159 |
| 131 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.82101229 |
| 132 | P300_19829295_ChIP-Seq_ESCs_Human | 0.82020348 |
| 133 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.81627717 |
| 134 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.81170251 |
| 135 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.80675639 |
| 136 | RXR_22108803_ChIP-Seq_LS180_Human | 0.80522016 |
| 137 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.80018752 |
| 138 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.79809317 |
| 139 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.79748458 |
| 140 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.79725548 |
| 141 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.79590521 |
| 142 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.79540351 |
| 143 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.78304877 |
| 144 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.76893612 |
| 145 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.75539806 |
| 146 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.75125786 |
| 147 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.74398182 |
| 148 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.74375913 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.18016750 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.05860781 |
| 3 | MP0005360_urolithiasis | 4.42052794 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.99149301 |
| 5 | MP0005365_abnormal_bile_salt | 3.80035022 |
| 6 | MP0002822_catalepsy | 3.13449689 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.07917981 |
| 8 | MP0003635_abnormal_synaptic_transmissio | 3.06458802 |
| 9 | MP0003880_abnormal_central_pattern | 2.83889131 |
| 10 | MP0004270_analgesia | 2.59304100 |
| 11 | MP0009745_abnormal_behavioral_response | 2.56568621 |
| 12 | MP0002063_abnormal_learning/memory/cond | 2.47753886 |
| 13 | MP0010329_abnormal_lipoprotein_level | 2.45488364 |
| 14 | MP0002064_seizures | 2.37672905 |
| 15 | MP0003252_abnormal_bile_duct | 2.32939577 |
| 16 | MP0009046_muscle_twitch | 2.08797456 |
| 17 | MP0001486_abnormal_startle_reflex | 2.02496060 |
| 18 | MP0002572_abnormal_emotion/affect_behav | 1.98773809 |
| 19 | MP0003329_amyloid_beta_deposits | 1.97096485 |
| 20 | MP0005423_abnormal_somatic_nervous | 1.92753908 |
| 21 | MP0005332_abnormal_amino_acid | 1.90624071 |
| 22 | MP0001968_abnormal_touch/_nociception | 1.85050307 |
| 23 | MP0009780_abnormal_chondrocyte_physiolo | 1.83527569 |
| 24 | MP0002272_abnormal_nervous_system | 1.83393538 |
| 25 | MP0003123_paternal_imprinting | 1.79762492 |
| 26 | MP0005083_abnormal_biliary_tract | 1.78771239 |
| 27 | MP0003195_calcinosis | 1.74645496 |
| 28 | MP0001501_abnormal_sleep_pattern | 1.64955275 |
| 29 | MP0002734_abnormal_mechanical_nocicepti | 1.61506202 |
| 30 | MP0003690_abnormal_glial_cell | 1.57985816 |
| 31 | MP0002909_abnormal_adrenal_gland | 1.56573065 |
| 32 | MP0002118_abnormal_lipid_homeostasis | 1.55204410 |
| 33 | MP0004885_abnormal_endolymph | 1.55029782 |
| 34 | MP0003806_abnormal_nucleotide_metabolis | 1.50231425 |
| 35 | MP0001666_abnormal_nutrient_absorption | 1.49045565 |
| 36 | MP0000566_synostosis | 1.47591977 |
| 37 | MP0009840_abnormal_foam_cell | 1.46969666 |
| 38 | MP0001440_abnormal_grooming_behavior | 1.42859214 |
| 39 | MP0008569_lethality_at_weaning | 1.41576924 |
| 40 | MP0001346_abnormal_lacrimal_gland | 1.40920810 |
| 41 | MP0000751_myopathy | 1.40792391 |
| 42 | MP0005646_abnormal_pituitary_gland | 1.40114564 |
| 43 | MP0000604_amyloidosis | 1.34849989 |
| 44 | MP0005623_abnormal_meninges_morphology | 1.34163115 |
| 45 | MP0003705_abnormal_hypodermis_morpholog | 1.33276638 |
| 46 | MP0002736_abnormal_nociception_after | 1.32205016 |
| 47 | MP0003633_abnormal_nervous_system | 1.30408715 |
| 48 | MP0003868_abnormal_feces_composition | 1.30265379 |
| 49 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.28355174 |
| 50 | MP0004858_abnormal_nervous_system | 1.26105204 |
| 51 | MP0005535_abnormal_body_temperature | 1.25365314 |
| 52 | MP0002067_abnormal_sensory_capabilities | 1.25274086 |
| 53 | MP0002733_abnormal_thermal_nociception | 1.24377607 |
| 54 | MP0004130_abnormal_muscle_cell | 1.24168771 |
| 55 | MP0002249_abnormal_larynx_morphology | 1.22185364 |
| 56 | MP0002557_abnormal_social/conspecific_i | 1.18906520 |
| 57 | MP0003879_abnormal_hair_cell | 1.18477847 |
| 58 | MP0004924_abnormal_behavior | 1.17783809 |
| 59 | MP0005386_behavior/neurological_phenoty | 1.17783809 |
| 60 | MP0003075_altered_response_to | 1.16599510 |
| 61 | MP0004019_abnormal_vitamin_homeostasis | 1.16285216 |
| 62 | MP0003283_abnormal_digestive_organ | 1.15954366 |
| 63 | MP0003122_maternal_imprinting | 1.15269755 |
| 64 | MP0008872_abnormal_physiological_respon | 1.14266656 |
| 65 | MP0005409_darkened_coat_color | 1.14245979 |
| 66 | MP0002735_abnormal_chemical_nociception | 1.12166826 |
| 67 | MP0001970_abnormal_pain_threshold | 1.12033963 |
| 68 | MP0008874_decreased_physiological_sensi | 1.11816258 |
| 69 | MP0004811_abnormal_neuron_physiology | 1.11538934 |
| 70 | MP0001348_abnormal_lacrimal_gland | 1.09608166 |
| 71 | MP0000955_abnormal_spinal_cord | 1.05895934 |
| 72 | MP0003631_nervous_system_phenotype | 1.05766817 |
| 73 | MP0000778_abnormal_nervous_system | 1.05567923 |
| 74 | MP0001502_abnormal_circadian_rhythm | 1.03978253 |
| 75 | MP0002066_abnormal_motor_capabilities/c | 1.03242471 |
| 76 | MP0003191_abnormal_cellular_cholesterol | 1.02515429 |
| 77 | MP0001984_abnormal_olfaction | 1.01324744 |
| 78 | MP0009379_abnormal_foot_pigmentation | 1.01142063 |
| 79 | MP0000609_abnormal_liver_physiology | 0.98686282 |
| 80 | MP0004142_abnormal_muscle_tone | 0.97172598 |
| 81 | MP0002090_abnormal_vision | 0.95292756 |
| 82 | MP0002089_abnormal_postnatal_growth/wei | 0.95093177 |
| 83 | MP0010234_abnormal_vibrissa_follicle | 0.93360260 |
| 84 | MP0004043_abnormal_pH_regulation | 0.93243978 |
| 85 | MP0003787_abnormal_imprinting | 0.93141079 |
| 86 | MP0000747_muscle_weakness | 0.92360203 |
| 87 | MP0002069_abnormal_eating/drinking_beha | 0.92166593 |
| 88 | MP0000579_abnormal_nail_morphology | 0.91486283 |
| 89 | MP0000920_abnormal_myelination | 0.91469553 |
| 90 | MP0005167_abnormal_blood-brain_barrier | 0.90518405 |
| 91 | MP0002876_abnormal_thyroid_physiology | 0.89329160 |
| 92 | MP0004742_abnormal_vestibular_system | 0.89018237 |
| 93 | MP0002184_abnormal_innervation | 0.88940419 |
| 94 | MP0005551_abnormal_eye_electrophysiolog | 0.88462452 |
| 95 | MP0001963_abnormal_hearing_physiology | 0.88272441 |
| 96 | MP0002882_abnormal_neuron_morphology | 0.88089283 |
| 97 | MP0001177_atelectasis | 0.87815126 |
| 98 | MP0000678_abnormal_parathyroid_gland | 0.87619884 |
| 99 | MP0008961_abnormal_basal_metabolism | 0.86011929 |
| 100 | MP0002837_dystrophic_cardiac_calcinosis | 0.85821094 |
| 101 | MP0005319_abnormal_enzyme/_coenzyme | 0.84511167 |
| 102 | MP0002229_neurodegeneration | 0.83276029 |
| 103 | MP0005670_abnormal_white_adipose | 0.80959348 |
| 104 | MP0003632_abnormal_nervous_system | 0.79838648 |
| 105 | MP0002078_abnormal_glucose_homeostasis | 0.78208508 |
| 106 | MP0006276_abnormal_autonomic_nervous | 0.76995390 |
| 107 | MP0003938_abnormal_ear_development | 0.76932952 |
| 108 | MP0004145_abnormal_muscle_electrophysio | 0.74109987 |
| 109 | MP0001485_abnormal_pinna_reflex | 0.72034663 |
| 110 | MP0003861_abnormal_nervous_system | 0.69986105 |
| 111 | MP0002152_abnormal_brain_morphology | 0.67238474 |
| 112 | MP0004085_abnormal_heartbeat | 0.66982690 |
| 113 | MP0005448_abnormal_energy_balance | 0.66130275 |
| 114 | MP0002138_abnormal_hepatobiliary_system | 0.65915219 |
| 115 | MP0004087_abnormal_muscle_fiber | 0.65525638 |
| 116 | MP0003137_abnormal_impulse_conducting | 0.64526652 |
| 117 | MP0001299_abnormal_eye_distance/ | 0.63555231 |
| 118 | MP0010769_abnormal_survival | 0.63089496 |
| 119 | MP0000639_abnormal_adrenal_gland | 0.62572108 |
| 120 | MP0003953_abnormal_hormone_level | 0.61115305 |
| 121 | MP0003634_abnormal_glial_cell | 0.61075746 |
| 122 | MP0000462_abnormal_digestive_system | 0.60835213 |
| 123 | MP0001905_abnormal_dopamine_level | 0.60647048 |
| 124 | MP0009672_abnormal_birth_weight | 0.59036418 |
| 125 | MP0003183_abnormal_peptide_metabolism | 0.58495504 |
| 126 | MP0001943_abnormal_respiration | 0.58287841 |
| 127 | MP0010768_mortality/aging | 0.58219514 |
| 128 | MP0005647_abnormal_sex_gland | 0.57786123 |
| 129 | MP0000026_abnormal_inner_ear | 0.57591890 |
| 130 | MP0004233_abnormal_muscle_weight | 0.57154889 |
| 131 | MP0000534_abnormal_ureter_morphology | 0.56990327 |
| 132 | MP0005166_decreased_susceptibility_to | 0.56974508 |
| 133 | MP0005645_abnormal_hypothalamus_physiol | 0.56806465 |
| 134 | MP0004147_increased_porphyrin_level | 0.56572946 |
| 135 | MP0002971_abnormal_brown_adipose | 0.55923301 |
| 136 | MP0002082_postnatal_lethality | 0.55763999 |
| 137 | MP0010770_preweaning_lethality | 0.55763999 |
| 138 | MP0000759_abnormal_skeletal_muscle | 0.55198726 |
| 139 | MP0001764_abnormal_homeostasis | 0.54525486 |
| 140 | MP0000681_abnormal_thyroid_gland | 0.54487199 |
| 141 | MP0001529_abnormal_vocalization | 0.53823423 |
| 142 | MP0005187_abnormal_penis_morphology | 0.53280453 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 5.28253815 |
| 2 | Deep venous thrombosis (HP:0002625) | 5.13276275 |
| 3 | Focal motor seizures (HP:0011153) | 4.85524289 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.71389988 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 4.40939849 |
| 6 | Obstructive sleep apnea (HP:0002870) | 4.02976532 |
| 7 | Hyperlipoproteinemia (HP:0010980) | 3.99751027 |
| 8 | Xanthomatosis (HP:0000991) | 3.92589715 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 3.89057305 |
| 10 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.75821059 |
| 11 | Focal seizures (HP:0007359) | 3.70625367 |
| 12 | Abnormality of binocular vision (HP:0011514) | 3.68555683 |
| 13 | Diplopia (HP:0000651) | 3.68555683 |
| 14 | Hypobetalipoproteinemia (HP:0003563) | 3.62674042 |
| 15 | Complement deficiency (HP:0004431) | 3.52168549 |
| 16 | Annular pancreas (HP:0001734) | 3.51944984 |
| 17 | Visual hallucinations (HP:0002367) | 3.32207750 |
| 18 | Insomnia (HP:0100785) | 3.32101842 |
| 19 | Hyperglycinemia (HP:0002154) | 3.30267428 |
| 20 | Ketosis (HP:0001946) | 3.28996451 |
| 21 | Action tremor (HP:0002345) | 3.26774660 |
| 22 | Hyperammonemia (HP:0001987) | 3.22340502 |
| 23 | Status epilepticus (HP:0002133) | 3.14630208 |
| 24 | Epidermoid cyst (HP:0200040) | 3.06380489 |
| 25 | Hyperventilation (HP:0002883) | 3.00960257 |
| 26 | Delayed CNS myelination (HP:0002188) | 2.97933833 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.92786019 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 2.92786019 |
| 29 | Generalized tonic-clonic seizures (HP:0002069) | 2.88860414 |
| 30 | Torticollis (HP:0000473) | 2.86592558 |
| 31 | Progressive cerebellar ataxia (HP:0002073) | 2.85282811 |
| 32 | Impaired social interactions (HP:0000735) | 2.83157756 |
| 33 | Abnormal social behavior (HP:0012433) | 2.83157756 |
| 34 | Hyperglycinuria (HP:0003108) | 2.82692802 |
| 35 | Dysdiadochokinesis (HP:0002075) | 2.82265987 |
| 36 | Epileptic encephalopathy (HP:0200134) | 2.81295927 |
| 37 | Abnormality of the lower motor neuron (HP:0002366) | 2.80442983 |
| 38 | Hypolipoproteinemia (HP:0010981) | 2.79393307 |
| 39 | Poor eye contact (HP:0000817) | 2.77691584 |
| 40 | Postural instability (HP:0002172) | 2.75381294 |
| 41 | Focal dystonia (HP:0004373) | 2.73209909 |
| 42 | Bundle branch block (HP:0011710) | 2.70767179 |
| 43 | Hyperacusis (HP:0010780) | 2.69011590 |
| 44 | Neurofibrillary tangles (HP:0002185) | 2.66706341 |
| 45 | Intention tremor (HP:0002080) | 2.66476491 |
| 46 | Truncal ataxia (HP:0002078) | 2.65648367 |
| 47 | Absence seizures (HP:0002121) | 2.64954525 |
| 48 | Hypoalphalipoproteinemia (HP:0003233) | 2.64497901 |
| 49 | Cerebral hypomyelination (HP:0006808) | 2.63473832 |
| 50 | Ketoacidosis (HP:0001993) | 2.63462266 |
| 51 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.62342829 |
| 52 | Joint hemorrhage (HP:0005261) | 2.59659486 |
| 53 | Abnormality of the common coagulation pathway (HP:0010990) | 2.59373370 |
| 54 | Anxiety (HP:0000739) | 2.59137128 |
| 55 | Conjugated hyperbilirubinemia (HP:0002908) | 2.58018286 |
| 56 | Craniofacial dystonia (HP:0012179) | 2.57195081 |
| 57 | Akinesia (HP:0002304) | 2.52501990 |
| 58 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.51731387 |
| 59 | Papilledema (HP:0001085) | 2.50520857 |
| 60 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.49865505 |
| 61 | Supranuclear gaze palsy (HP:0000605) | 2.49718019 |
| 62 | Dysmetria (HP:0001310) | 2.48683494 |
| 63 | Hypoglycemic coma (HP:0001325) | 2.48190512 |
| 64 | Bronchomalacia (HP:0002780) | 2.47433998 |
| 65 | Gout (HP:0001997) | 2.46262993 |
| 66 | Peripheral hypomyelination (HP:0007182) | 2.45299200 |
| 67 | Aplasia involving bones of the extremities (HP:0009825) | 2.43969819 |
| 68 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.43969819 |
| 69 | Aplasia of the phalanges of the hand (HP:0009802) | 2.43969819 |
| 70 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.41624299 |
| 71 | Febrile seizures (HP:0002373) | 2.40507860 |
| 72 | Sleep apnea (HP:0010535) | 2.39555356 |
| 73 | Limb dystonia (HP:0002451) | 2.39367325 |
| 74 | Cerebral inclusion bodies (HP:0100314) | 2.37970528 |
| 75 | Depression (HP:0000716) | 2.37302698 |
| 76 | Dialeptic seizures (HP:0011146) | 2.36934287 |
| 77 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.34507605 |
| 78 | Abnormal eating behavior (HP:0100738) | 2.32239216 |
| 79 | Neuronal loss in central nervous system (HP:0002529) | 2.31062148 |
| 80 | Lower limb amyotrophy (HP:0007210) | 2.30792042 |
| 81 | Neonatal onset (HP:0003623) | 2.26955741 |
| 82 | Fat malabsorption (HP:0002630) | 2.25297651 |
| 83 | Hypercholesterolemia (HP:0003124) | 2.25285012 |
| 84 | Abnormality of methionine metabolism (HP:0010901) | 2.25018292 |
| 85 | Atonic seizures (HP:0010819) | 2.24886887 |
| 86 | Abnormality of complement system (HP:0005339) | 2.24787469 |
| 87 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.23561884 |
| 88 | Ankle clonus (HP:0011448) | 2.22724460 |
| 89 | Scanning speech (HP:0002168) | 2.19576158 |
| 90 | Gaze-evoked nystagmus (HP:0000640) | 2.18014149 |
| 91 | Rigidity (HP:0002063) | 2.17752911 |
| 92 | Clonus (HP:0002169) | 2.17749392 |
| 93 | Tetraplegia (HP:0002445) | 2.17700655 |
| 94 | Hemiplegia (HP:0002301) | 2.16248867 |
| 95 | Pointed chin (HP:0000307) | 2.15089667 |
| 96 | Impaired vibratory sensation (HP:0002495) | 2.14687128 |
| 97 | Heart block (HP:0012722) | 2.14367603 |
| 98 | Delusions (HP:0000746) | 2.12822448 |
| 99 | Sensorimotor neuropathy (HP:0007141) | 2.12466338 |
| 100 | Overriding aorta (HP:0002623) | 2.10563586 |
| 101 | Foot dorsiflexor weakness (HP:0009027) | 2.09046814 |
| 102 | Dysmetric saccades (HP:0000641) | 2.08958369 |
| 103 | Abnormal atrioventricular conduction (HP:0005150) | 2.08363706 |
| 104 | Broad-based gait (HP:0002136) | 2.07646433 |
| 105 | Hyperbilirubinemia (HP:0002904) | 2.07246885 |
| 106 | Spastic gait (HP:0002064) | 2.06598032 |
| 107 | Sudden death (HP:0001699) | 2.05038444 |
| 108 | Spontaneous abortion (HP:0005268) | 2.03642020 |
| 109 | Distal upper limb amyotrophy (HP:0007149) | 2.03126553 |
| 110 | Upper limb amyotrophy (HP:0009129) | 2.03126553 |
| 111 | Genetic anticipation (HP:0003743) | 2.00430856 |
| 112 | Abnormal gallbladder physiology (HP:0012438) | 2.00320805 |
| 113 | Cholecystitis (HP:0001082) | 2.00320805 |
| 114 | Skin nodule (HP:0200036) | 1.99841986 |
| 115 | Ventricular fibrillation (HP:0001663) | 1.99640319 |
| 116 | Hyperparathyroidism (HP:0000843) | 1.99179888 |
| 117 | Generalized myoclonic seizures (HP:0002123) | 1.98909597 |
| 118 | Hyporeflexia of lower limbs (HP:0002600) | 1.98490711 |
| 119 | Lower limb muscle weakness (HP:0007340) | 1.97460159 |
| 120 | Hyperthyroidism (HP:0000836) | 1.97459059 |
| 121 | Increased circulating renin level (HP:0000848) | 1.96700905 |
| 122 | Amblyopia (HP:0000646) | 1.95401033 |
| 123 | Shallow orbits (HP:0000586) | 1.94942121 |
| 124 | Apathy (HP:0000741) | 1.94845100 |
| 125 | Megalencephaly (HP:0001355) | 1.94449378 |
| 126 | Abnormality of the foot musculature (HP:0001436) | 1.93790968 |
| 127 | Mutism (HP:0002300) | 1.93577364 |
| 128 | Hypsarrhythmia (HP:0002521) | 1.93359389 |
| 129 | EEG with generalized epileptiform discharges (HP:0011198) | 1.93319354 |
| 130 | Epileptiform EEG discharges (HP:0011182) | 1.92950669 |
| 131 | Confusion (HP:0001289) | 1.92138448 |
| 132 | Stereotypic behavior (HP:0000733) | 1.92017844 |
| 133 | Truncus arteriosus (HP:0001660) | 1.91485752 |
| 134 | Spastic tetraparesis (HP:0001285) | 1.91451084 |
| 135 | Hypoglycemic seizures (HP:0002173) | 1.90927721 |
| 136 | Atrioventricular block (HP:0001678) | 1.90877379 |
| 137 | Abnormality of the intrinsic pathway (HP:0010989) | 1.90776083 |
| 138 | Lower limb asymmetry (HP:0100559) | 1.90714229 |
| 139 | Amyloidosis (HP:0011034) | 1.90154397 |
| 140 | Abnormality of the Achilles tendon (HP:0005109) | 1.90012069 |
| 141 | Bradykinesia (HP:0002067) | 1.89490603 |
| 142 | Exercise-induced myalgia (HP:0003738) | 1.88659054 |
| 143 | Abnormality of serum amino acid levels (HP:0003112) | 1.86741307 |
| 144 | Elfin facies (HP:0004428) | 1.86434623 |
| 145 | Abnormality of the periventricular white matter (HP:0002518) | 1.86210283 |
| 146 | Hammertoe (HP:0001765) | 1.85869726 |
| 147 | Urinary urgency (HP:0000012) | 1.83733140 |
| 148 | Turricephaly (HP:0000262) | 1.83688601 |
| 149 | Rapidly progressive (HP:0003678) | 1.83629438 |
| 150 | Drooling (HP:0002307) | 1.83191931 |
| 151 | Spinal canal stenosis (HP:0003416) | 1.82394617 |
| 152 | Athetosis (HP:0002305) | 1.78855805 |
| 153 | Choreoathetosis (HP:0001266) | 1.75719659 |
| 154 | Bowel incontinence (HP:0002607) | 1.74871617 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.54264110 |
| 2 | NTRK3 | 3.51509974 |
| 3 | MAP3K9 | 3.21803777 |
| 4 | DAPK2 | 3.07034773 |
| 5 | MARK1 | 2.75532934 |
| 6 | MAP3K4 | 2.54694356 |
| 7 | MAP2K4 | 2.34487102 |
| 8 | PAK6 | 2.23844454 |
| 9 | PRKD3 | 2.20823327 |
| 10 | MINK1 | 2.20483779 |
| 11 | CAMKK1 | 2.18213516 |
| 12 | NTRK2 | 2.07574800 |
| 13 | KSR2 | 2.00745854 |
| 14 | MAP2K7 | 1.97387290 |
| 15 | NTRK1 | 1.67768591 |
| 16 | TRIB3 | 1.67112692 |
| 17 | STK38 | 1.60867641 |
| 18 | EEF2K | 1.60128208 |
| 19 | PINK1 | 1.58445946 |
| 20 | BCKDK | 1.47272108 |
| 21 | CDK5 | 1.38176791 |
| 22 | SGK223 | 1.37028521 |
| 23 | SGK494 | 1.37028521 |
| 24 | TYRO3 | 1.30700516 |
| 25 | KSR1 | 1.28782282 |
| 26 | SGK3 | 1.26010687 |
| 27 | SGK2 | 1.24148170 |
| 28 | MAP3K13 | 1.23978893 |
| 29 | PRKCG | 1.21041018 |
| 30 | DAPK1 | 1.19815786 |
| 31 | TNIK | 1.17560605 |
| 32 | SIK2 | 1.16630850 |
| 33 | SIK1 | 1.14275245 |
| 34 | CAMK1G | 1.14046429 |
| 35 | MAP3K2 | 1.11162716 |
| 36 | PHKG2 | 1.10170262 |
| 37 | PHKG1 | 1.10170262 |
| 38 | TAOK1 | 1.07961454 |
| 39 | PRPF4B | 1.07880110 |
| 40 | MAP3K7 | 1.06059140 |
| 41 | BRSK1 | 1.05810531 |
| 42 | PRKCH | 1.04998857 |
| 43 | FES | 1.03816021 |
| 44 | CAMK1 | 1.00180812 |
| 45 | FGFR2 | 0.98572946 |
| 46 | RET | 0.98251301 |
| 47 | PDPK1 | 0.93519650 |
| 48 | STK11 | 0.93440403 |
| 49 | LMTK2 | 0.90976659 |
| 50 | RIPK1 | 0.90927545 |
| 51 | SMG1 | 0.90418767 |
| 52 | BRAF | 0.90093862 |
| 53 | RIPK4 | 0.88895563 |
| 54 | GRK5 | 0.88600628 |
| 55 | PDK1 | 0.85826825 |
| 56 | PRKCZ | 0.83148766 |
| 57 | CAMK2A | 0.83093929 |
| 58 | CAMKK2 | 0.81864033 |
| 59 | INSRR | 0.81176029 |
| 60 | LIMK1 | 0.79957458 |
| 61 | PAK3 | 0.78974640 |
| 62 | ARAF | 0.78107610 |
| 63 | LATS2 | 0.77462737 |
| 64 | UHMK1 | 0.77322864 |
| 65 | PLK2 | 0.76591603 |
| 66 | OXSR1 | 0.75959176 |
| 67 | MAPK10 | 0.73854251 |
| 68 | CDK19 | 0.73514224 |
| 69 | TESK1 | 0.70941942 |
| 70 | SGK1 | 0.70897751 |
| 71 | FGFR4 | 0.69909585 |
| 72 | WNK1 | 0.69634702 |
| 73 | MAPK13 | 0.68561807 |
| 74 | CAMK2G | 0.67331111 |
| 75 | MAP3K1 | 0.66534343 |
| 76 | CAMK4 | 0.65766425 |
| 77 | CAMK2B | 0.65679764 |
| 78 | CDK15 | 0.64907474 |
| 79 | MARK2 | 0.63808057 |
| 80 | PKN2 | 0.63707922 |
| 81 | PNCK | 0.63592744 |
| 82 | PDGFRA | 0.63464912 |
| 83 | DAPK3 | 0.63460221 |
| 84 | CDK18 | 0.62587836 |
| 85 | CSNK1G2 | 0.62366628 |
| 86 | CAMK1D | 0.61606720 |
| 87 | ALK | 0.61170348 |
| 88 | PRKG2 | 0.60665758 |
| 89 | CDK14 | 0.59143021 |
| 90 | MAP3K11 | 0.58554601 |
| 91 | MAP3K12 | 0.58358749 |
| 92 | ROCK2 | 0.57910838 |
| 93 | RPS6KA3 | 0.57397490 |
| 94 | CDK12 | 0.56827869 |
| 95 | ICK | 0.56601038 |
| 96 | PTK2B | 0.53865971 |
| 97 | CDK11A | 0.53282971 |
| 98 | CAMK2D | 0.51747977 |
| 99 | ERBB2 | 0.51740275 |
| 100 | PTK2 | 0.51359181 |
| 101 | MAPK12 | 0.51270282 |
| 102 | PRKACG | 0.50406250 |
| 103 | RAF1 | 0.48661838 |
| 104 | CASK | 0.48061593 |
| 105 | DYRK1A | 0.47951106 |
| 106 | CDC42BPA | 0.46922487 |
| 107 | TNK2 | 0.46764986 |
| 108 | IRAK2 | 0.46272900 |
| 109 | ERBB4 | 0.46054719 |
| 110 | FYN | 0.45198704 |
| 111 | DMPK | 0.44958869 |
| 112 | NEK1 | 0.43807271 |
| 113 | AKT2 | 0.43545267 |
| 114 | PKN1 | 0.43051689 |
| 115 | MAP2K1 | 0.42256805 |
| 116 | NEK6 | 0.41351232 |
| 117 | MAPKAPK5 | 0.40793157 |
| 118 | PRKAA1 | 0.39722053 |
| 119 | ROCK1 | 0.39143869 |
| 120 | EPHA2 | 0.37209488 |
| 121 | TTN | 0.37165458 |
| 122 | MTOR | 0.34518729 |
| 123 | RPS6KA2 | 0.33360862 |
| 124 | TAOK2 | 0.33000542 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 5.29054953 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.21676238 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.83087230 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.78064842 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.15930096 |
| 6 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.09867840 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.05078890 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.92055538 |
| 9 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.86944018 |
| 10 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.85910995 |
| 11 | Nicotine addiction_Homo sapiens_hsa05033 | 1.80191886 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.70779963 |
| 13 | Bile secretion_Homo sapiens_hsa04976 | 1.69629144 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.68428716 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.60982413 |
| 16 | GABAergic synapse_Homo sapiens_hsa04727 | 1.60250612 |
| 17 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.59815322 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.52184788 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.48962846 |
| 20 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.45604080 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.45087586 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.39867712 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.38480905 |
| 24 | Olfactory transduction_Homo sapiens_hsa04740 | 1.37675610 |
| 25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.36321456 |
| 26 | Circadian entrainment_Homo sapiens_hsa04713 | 1.32772896 |
| 27 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.25328565 |
| 28 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.23924980 |
| 29 | Morphine addiction_Homo sapiens_hsa05032 | 1.21880468 |
| 30 | Melanogenesis_Homo sapiens_hsa04916 | 1.20243109 |
| 31 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.19368674 |
| 32 | Peroxisome_Homo sapiens_hsa04146 | 1.18894971 |
| 33 | Long-term potentiation_Homo sapiens_hsa04720 | 1.17581957 |
| 34 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.16958145 |
| 35 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.16204400 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.15063581 |
| 37 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.12120039 |
| 38 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.11946820 |
| 39 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.08836959 |
| 40 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.07063156 |
| 41 | Salivary secretion_Homo sapiens_hsa04970 | 1.06543139 |
| 42 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.06433471 |
| 43 | Insulin secretion_Homo sapiens_hsa04911 | 1.05312404 |
| 44 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.04491495 |
| 45 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.03890701 |
| 46 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.03574977 |
| 47 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.01232575 |
| 48 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.94881056 |
| 49 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.94805938 |
| 50 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.94329752 |
| 51 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.93386082 |
| 52 | Histidine metabolism_Homo sapiens_hsa00340 | 0.90199138 |
| 53 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.89998638 |
| 54 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.88463543 |
| 55 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.87933196 |
| 56 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.87392245 |
| 57 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.87390941 |
| 58 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.86658710 |
| 59 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.86120370 |
| 60 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.83100069 |
| 61 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.81173602 |
| 62 | Cocaine addiction_Homo sapiens_hsa05030 | 0.80403114 |
| 63 | Retinol metabolism_Homo sapiens_hsa00830 | 0.78439432 |
| 64 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.78164071 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.77977355 |
| 66 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.76403144 |
| 67 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.75838485 |
| 68 | Axon guidance_Homo sapiens_hsa04360 | 0.74668127 |
| 69 | ABC transporters_Homo sapiens_hsa02010 | 0.74265179 |
| 70 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.73529472 |
| 71 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.72702072 |
| 72 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.72487847 |
| 73 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.72401803 |
| 74 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.71714590 |
| 75 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.69916188 |
| 76 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.69038727 |
| 77 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.68862355 |
| 78 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.68682920 |
| 79 | Renin secretion_Homo sapiens_hsa04924 | 0.68666271 |
| 80 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.68231441 |
| 81 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.67799807 |
| 82 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.67079599 |
| 83 | Carbon metabolism_Homo sapiens_hsa01200 | 0.66774282 |
| 84 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.66126839 |
| 85 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65230833 |
| 86 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.63897217 |
| 87 | Taste transduction_Homo sapiens_hsa04742 | 0.63805291 |
| 88 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.63678646 |
| 89 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.63168782 |
| 90 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.62883183 |
| 91 | Long-term depression_Homo sapiens_hsa04730 | 0.61423610 |
| 92 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.60789501 |
| 93 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.59104019 |
| 94 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.58606020 |
| 95 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.58588014 |
| 96 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.58327998 |
| 97 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.57671438 |
| 98 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.57572650 |
| 99 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.57081036 |
| 100 | Tight junction_Homo sapiens_hsa04530 | 0.56373881 |
| 101 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55366462 |
| 102 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.54264702 |
| 103 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.54070933 |
| 104 | Prion diseases_Homo sapiens_hsa05020 | 0.52498297 |
| 105 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.52286117 |
| 106 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51992751 |
| 107 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51508982 |
| 108 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49257527 |
| 109 | Endometrial cancer_Homo sapiens_hsa05213 | 0.47600251 |
| 110 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.47561197 |
| 111 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.46812457 |
| 112 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46408743 |
| 113 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.45655735 |
| 114 | Lysine degradation_Homo sapiens_hsa00310 | 0.45059445 |
| 115 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.44782193 |
| 116 | Endocytosis_Homo sapiens_hsa04144 | 0.44513449 |
| 117 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.43967247 |
| 118 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.43260936 |
| 119 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43102616 |
| 120 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.42602728 |
| 121 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.42568859 |
| 122 | Mineral absorption_Homo sapiens_hsa04978 | 0.42448146 |
| 123 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.41500860 |
| 124 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.41454720 |
| 125 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.41010464 |
| 126 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.40711570 |
| 127 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.40018585 |
| 128 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.39832810 |
| 129 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.39762006 |
| 130 | Gap junction_Homo sapiens_hsa04540 | 0.39567030 |
| 131 | Glioma_Homo sapiens_hsa05214 | 0.39366317 |
| 132 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.38403973 |
| 133 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.37224057 |
| 134 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.36878370 |
| 135 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.36424872 |
| 136 | Circadian rhythm_Homo sapiens_hsa04710 | 0.36065131 |
| 137 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35617327 |
| 138 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35473861 |
| 139 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.35067158 |
| 140 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.34023758 |
| 141 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.33844514 |

